Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Short-Acting Insulins for Mealtime Glucose Control in Diabetes Management

Pharmacological Properties of Short-Acting Insulin Analogs

  • Short-acting insulin analogs have a more rapid onset of action and shorter duration of action compared to regular human insulin, according to the American Diabetes Association 1

Dosing Recommendations

  • Initial dosing for mealtime insulin is typically 4 units per meal or 0.1 units/kg per meal, as recommended by the American Association of Clinical Endocrinologists 1
  • Dose adjustments should be based on blood glucose monitoring, considering factors such as carbohydrate content of meals, as suggested by the American Diabetes Association 2
  • Dose adjustments should also consider anticipated physical activity, as recommended by the American College of Sports Medicine 3

Meal Planning and Insulin Matching

  • Patients using short-acting insulins should learn carbohydrate counting to match insulin doses to carbohydrate intake, according to the Academy of Nutrition and Dietetics 2
  • Insulin doses may need adjustment if physical activity is performed within 1-2 hours of injection, as suggested by the American College of Sports Medicine 2

Mixing Insulin Considerations

  • Insulin glargine should not be mixed with other forms of insulin due to its low pH, as recommended by the American Diabetes Association 5

Hypoglycemia Management

  • Treatment of hypoglycemia should include 15-20g of glucose, as recommended by the American Diabetes Association 2
  • If hypoglycemia persists after 15-20 minutes, the treatment should be repeated, as suggested by the American Association of Clinical Endocrinologists 4

Common Pitfalls and Considerations

  • Patients must understand the rapid onset of action of short-acting analogs to avoid unexpected hypoglycemia, as recommended by the American Association of Clinical Endocrinologists 1
  • Patients should not skip meals when using short-acting insulins to reduce hypoglycemia risk, as suggested by the Academy of Nutrition and Dietetics 2